News & Events

News
Events

New View Surgical, Inc. Selected for MassChallenge 2016 Accelerator - Joins 128 startups from around the world for 4-month program in Boston

May 2016

BOSTON, May 19, 2016 – Today New View Surgical, Inc. announced it will join MassChallenge Boston, the most startup-friendly accelerator on the planet. One of 128 startups participating, New View Surgical, Inc. will benefit from mentorship, office space, and a vast network of experienced entrepreneurs, corporate partners, and investors. In November, all MassChallenge Boston startups will compete for $1.5M total in cash awards with no equity taken.

“The team at New View Surgical, Inc. is extremely proud of being selected as a Finalist from over 1,700 applicants for the MassChallenge 2016 Accelerator. We fully expect that the extensive network of entrepreneurs, business partners and investors associated with MassChallenge will help propel New View Surgical toward achieving our goal of commercializing the VisionPort™, our novel, game-changing surgical imaging technology that aims to redefine and simplify laparoscopic surgery”, commented Bryce Klontz, New View Surgical’s President and CEO.

“We received consistent feedback from our judges about the quality of applicants this year, and I'm confident we’ll have an incredibly high-caliber class of entrepreneurs joining us in Boston," added MassChallenge Boston Managing Director Scott Bailey. "These entrepreneurs will be challenged throughout the program to impact communities and provide disruptive solutions across a wide range of industries. Be on the lookout for them this summer!”

This year’s MassChallenge Boston class was selected from more than 1,700 applicants across a diverse range of industries and geographies, including 65 countries and 37 states. The accelerator program will culminate on November 2, 2016, at the MassChallenge Boston Awards Ceremony, where entrepreneurs will pitch their startups with the chance to win a share of $1.5 million in zero-equity awards.


New View Surgical, Inc. to Present at Emerging Technology Summit in San Francisco

May 2016
New View Surgical, Inc., an early-stage surgical imaging company in Boston, Massachusetts, announced today that it has been selected as a Presenting Company at the upcoming 2016 Emerging Medical Technology Summit to be held in San Francisco, November 9-11, 2016. The prestigious EMT Summit is co-hosted by Life Science Intelligence and The MedTech Strategist and will feature presentations by CEOs of 70 hand-picked early-stage medical device companies from around the world raising capital and/or seeking quality strategic partners.


New View Surgical, Inc. Names Bryce Klontz as President & CEO

February 2016
New View Surgical, Inc., an early-stage surgical imaging company in Boston, Massachusetts, announced today that it has named Bryce Klontz as President &CEO, effective immediately. Mr. Klontz is an accomplished global sales and marketing executive, having built and led commercial teams in the US, Europe and Asia. Most recently, Mr. Klontz was the Vice President of Commercial Strategy, Emerging Markets at Covidien, PLC where he led efforts to build commercial capabilities within the $1.5B+ Asia, Latin America, Emerging Europe, Middle East and Africa geographies. Mr. Klontz spent 14 years at Covidien in various leadership roles including Marketing Director in both the US and Europe, as well as 3 years as Vice President, Surgical Devices Business Unit, in Asia. Mr. Klontz also served as the global post-M&A integration lead for two of Covidien's most impactful acquisitions. Earlier in his career, Mr. Klontz played a pivotal role in the global launch of The CO2 Heart Laser System. Mr. Klontz received his MBA in marketing and finance from Carroll School of Management at Boston College and a Bachelor's degree from Northwestern University.


New View Surgical, Inc. Announces U.S. Patent for VisionPort™ Technology

September 2014
New View Surgical, Inc., an early-stage surgical imaging company in Boston, Massachusetts, announced today that the U.S. Patent and Trademark Office has issued a patent for the design behind the company’s entry device, the VisionPort™. The recently-issued patent (U.S. Patent Number 8,834,358 B2) is an extension of the Company’s initial patent (US Patent# 8,439,830 B2) issued in May 14, 2014 and was issued for a cannula-based system with an integrated camera and illumination. With this exclusive technology, visualization of the operative field is under the direct control of the primary surgeon through each one of his or her access ports, improving surgical outcomes and procedural efficiency.

Upcoming Events

2017 Angel Capital Association Summit and 5th Annual Innovation Showcase
April 26-28, 2017, San Francisco Marriott Marquis
780 Mission Street, San Francisco, CA 94103
www.angelcapitalassociation.org/2017-innovation-showcase/



Past Events


Society of American Gastrointestinal and Endoscopic Surgeons (SAGES)
March 22-25, 2017, Houston, TX



Angel Capital Expo
March 16, 2017, Microsoft Building 33, Redmond, Washington
Presenter: Keiretsu Forum Angel Capital Expo



RESI Conference
January 10, 2017, Marine’s Memorial Club & Hotel
609 Sutter Street, San Francisco, CA 94102



August 31 – September 3, 2016, Westin Copley Place Hotel, Boston, MA

Minimally Invasive Surgery Week


October 28, 2016, Westin, Waltham, Massachusetts

Presenter. MassMEDIC MedTech Showcase
www.massmedic.com


November 9-11, 2016, Hotel Sofitel San Francisco, CA

Presenter. Emerging Medical Technologies Summit


March 16-19, 2016, Boston, MA

Society of American Gastrointestinal and Endoscopic Surgeons (SAGES)